SERAFs grant from the Research Council of Norway enables SERAF to perform clinical addiction research at an international level and contributes to a more sufficient, evidence-based treatment of addiction disorders.
To meet the request from the research council we have significantly increased our alcohol research. We conduct extensive dissemination of addiction research through publications, lectures, courses, supervision and teaching of master and PhD students.
SERAF has a broad national and international network in the field of clinical addiction research.
Covid-19 and the treatment of substance use disorders
Apr. 15, 2020 5:51 PM
A recent paper on Covid-19 and the treatment of substance use disorders with a focus on opioid agonist treatment, published by a large international group with contributions also from SERAF.
Information from the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Norway, about special measures for vulnerable groups with substance use disorders (SUD) during the Coronavirus epidemic
Mar. 15, 2020 2:05 PM
The Coronavirus is now spreading in most populations worldwide. Persons with SUD, both in and out of treatment, must be considered as extra vulnerable groups in this context.
Opioid maintenance treatment reduces mortality
Aug. 13, 2019 3:14 PM
The effect of opioid maintenance treatment (OMT) on overdose mortality varies both between and within countries. Consequently, treatment programs need to be evaluated in different treatment settings and over time within settings.
- Stimulant medication for ADHD in opioid maintenance treatment Dec. 1, 2014 12:02 PM
- From methadone to buprenorphine: Changes during a 10 year period within a national opioid maintenance treatment programme Sep. 18, 2014 3:33 PM
- Motivational intervention to enhance post-detoxification 12-Step group affiliation: a randomized controlled trial Sep. 18, 2014 3:24 PM